Updated Story As legislative efforts to advance patent reform bills steam up in Congress, the Campaign for Sustainable Rx Pricing (CSRxP) has launched a new multi-million-dollar initiative aimed at exposing how pharmaceutical companies manipulate the patent system, a key driver of high prescription drug prices in the United States. Some experts argue that reforming patent laws would be a more effective solution for lowering drug costs than relying on Medicare negotiations. The move follows the Senate’s unanimous...